These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22507995)

  • 1. [Neisseria meningitidis: new vaccines and preventive strategies].
    Morciano L; Zaratti L; Franco E
    Ig Sanita Pubbl; 2012; 68(1):97-104. PubMed ID: 22507995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neisseria meningitidis B vaccines.
    Panatto D; Amicizia D; Lai PL; Gasparini R
    Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of new vaccines against meningococcal disease.
    Bröker M
    Arzneimittelforschung; 2003; 53(12):805-13. PubMed ID: 14732960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
    Magdzik W
    Przegl Epidemiol; 2004; 58(2):241-51. PubMed ID: 15521103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination.
    Trotter CL; Gay NJ; Edmunds WJ
    Am J Epidemiol; 2005 Jul; 162(1):89-100. PubMed ID: 15961591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningococcal disease in the Netherlands: media hype, but not an epidemic].
    van Furth AM; Zaaijer HL
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1716-8. PubMed ID: 11572168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region.
    Soriano-Gabarró M; Wolter J; Hogea C; Vyse A
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):761-74. PubMed ID: 21905785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.
    Poland GA
    Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for the prevention of meningococcal disease in children.
    Soriano-Gabarró M; Stuart JM; Rosenstein NE
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):182-9. PubMed ID: 12199614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine.
    Bröker M; Veitch K
    Travel Med Infect Dis; 2010 Jan; 8(1):47-50. PubMed ID: 20188306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a meningitis-free world.
    Black S; Pizza M; Nissum M; Rappuoli R
    Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].
    Chippaux JP; Debois H; Saliou P
    Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances towards the prevention of meningococcal B disease: a multidimensional story.
    Roderick M; Finn A
    J Infect; 2014 Jan; 68 Suppl 1():S76-82. PubMed ID: 24139188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Ceccherini V; Taddei C; Balocchini E; Bonanni P
    J Prev Med Hyg; 2012 Jun; 53(2):61-7. PubMed ID: 23240162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.